Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights a strong focus on Bitcoin acquisitions, which exposes the company to volatility and regulatory risks. Despite cash generation and Bitcoin gains, the healthcare business faces challenges and lacks clear growth guidance. The $500 million ATM program and convertible notes increase financial leverage. The Q&A session reveals concerns about unclear management responses and potential declines in healthcare revenue. These factors, along with the economic and competitive pressures, suggest a negative sentiment, likely resulting in a stock price decline of -2% to -8%.
Key Financial Performance
Bitcoin Acquired 1,510 bitcoins (up from previous acquisitions), resulting in a BTC dollar gain of $52 million.
Total Bitcoin Holdings 3,808 bitcoins valued at almost $400 million, making Semler the fourth largest bitcoin treasury company in the U.S.
BTC Yield 22.2% for 2025, with a total BTC gain of 510 bitcoins.
Total BTC Gain Since Adoption 1,447 bitcoins and a BTC dollar gain of $139 million since May 28, 2024.
Stock Appreciation 64% in less than 12 months, compared to 9% for the S&P 500.
Convertible Note Financing Completed a $100 million financing round, using most of the net proceeds to buy bitcoin.
ATM Program New $500 million ATM program effective April 22, 2025.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Revenue Opportunity: Pursuing a new revenue opportunity in the cardiovascular space with existing large enterprise customer base.
510(k) Clearance: Development and marketing of additional products including receipt and timing of an additional 510(k) clearance for QuantaFlo.
Bitcoin Treasury Strategy: Acquired 1,510 bitcoins in 2025, with a BTC dollar gain of $52 million.
Corporate Bitcoin Treasury: Fourth largest bitcoin treasury company in the U.S. with 3,808 bitcoins worth almost $400 million.
Cash Generation: Managing the healthcare business to generate cash primarily for additional Bitcoin purchases.
Convertible Note Financing: Completed a $100 million convertible note financing round to buy bitcoin.
ATM Program: New $500 million ATM program effective April 22 to support bitcoin acquisitions.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Bitcoin Treasury Strategy Risks: The company's reliance on Bitcoin as a primary treasury reserve asset exposes it to significant market volatility and regulatory uncertainties surrounding cryptocurrency.
Healthcare Business Challenges: Despite strong performance in Bitcoin investments, the healthcare business faces headwinds that could impact cash generation and overall financial stability.
Regulatory Issues: The proposed settlement with the U.S. Department of Justice introduces potential legal risks that could affect the company's operations and financial health.
Economic Factors: The overall economic environment, including inflation and market conditions, may impact the company's ability to execute its business strategies effectively.
Competitive Pressures: Increased competition in both the healthcare and cryptocurrency sectors could pose challenges to maintaining market position and profitability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Healthcare Business Expansion: Pursuing a new revenue opportunity in the cardiovascular space with existing large enterprise customer base.
Bitcoin Treasury Strategy: Plans to acquire additional Bitcoin and manage healthcare business to generate cash primarily for Bitcoin purchases.
Bitcoin Acquisition: Acquired 1,510 bitcoins in 2025, totaling 3,808 bitcoins worth almost $400 million.
ATM Program: New $500 million ATM program effective April 22, 2025, to support Bitcoin acquisitions.
Bitcoin Yield: Achieved a BTC yield of 22.2% in 2025, with a BTC dollar gain of $52 million.
Stock Performance: Stock appreciated 64% in less than 12 months.
Future Bitcoin Goals: Ambitious goals for growing Bitcoin arsenal in 2025.
Convertible Note Financing: Completed a $100 million convertible note financing round to buy Bitcoin.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
ATM Program: A new $500 million ATM program became effective on April 22, 2025.
Convertible Note Financing: Completed a $100 million convertible note financing round, using most of the net proceeds to buy bitcoin.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are your plans this year for accumulating more bitcoin?
A:We have extremely ambitious plans to accretively acquire more bitcoin. We want to aggressively increase our $388 million, close to $400 million now, bitcoin stockpile and are well on our way with our recently authorized $500 million ATM.
Q:What’s driving the underlying trends in the business? And what do you expect for 2025?
A:Despite the government decision about payment for risk adjustment for PAD, we continue to see ongoing testing and additions to our customer base, albeit at decreased volumes for PAD. Our priority for 2025 is to minimize declines to QuantaFlo revenue while maintaining sufficient infrastructure to support, innovate and grow our operations related to other cardiovascular disease states.
Q:Review of Unclear Management Responses
A:Management did not provide specific details on the expected revenue growth or the impact of the government decision on their business, which lacked clarity.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Department Justice
Dr Chutorian
Expansion health
Instructions event
Justice statement
Private Securities
QuantaFlo settlement
Scientific Financial
Scientific afternoon
Scientific comment
Securities Litigation
Transcript afternoon
base opportunity
care development
cash purchase
enterprise customer
expectation treasury
healthcare cash
healthcare opportunity
investor relation
mode Instructions
opportunity healthcare
opportunity price
opportunity space
participant mode
price Expansion
purchase update
relation page
release investor
result healthcare
semlerscientificcom Dr
settlement Department
space enterprise
treasury opportunity
update Treasury
website semlerscientificcom
SMLR Transcript
Semler Scientific, Inc. (SMLR) Q2 2025 Earnings Call Transcript
Unknown8-4
The earnings call reveals several concerns: declining revenue and operating losses in the healthcare segment, significant risk from heavy Bitcoin investments, legal expenses from a DOJ settlement, and reliance on equity issuance, which could dilute shareholder value. While there is a positive Bitcoin yield, the volatility and risks associated with Bitcoin, combined with a weak healthcare business performance, outweigh the positives. The Q&A session did not alleviate these concerns, as management's optimism about Bitcoin adoption does not mitigate the financial and operational risks. Overall, these factors suggest a negative stock price reaction.
Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2025 Earnings Call Transcript
Unknown5-14
The earnings call highlights a strong focus on Bitcoin acquisitions, which exposes the company to volatility and regulatory risks. Despite cash generation and Bitcoin gains, the healthcare business faces challenges and lacks clear growth guidance. The $500 million ATM program and convertible notes increase financial leverage. The Q&A session reveals concerns about unclear management responses and potential declines in healthcare revenue. These factors, along with the economic and competitive pressures, suggest a negative sentiment, likely resulting in a stock price decline of -2% to -8%.
Semler Scientific, Inc. (SMLR) Q1 2025 Earnings Call Transcript
Unknown5-13
The earnings call highlights significant financial struggles, including a 44% revenue decline, operational losses, and liquidity concerns. Despite ambitious Bitcoin acquisition plans, the volatility poses financial risks. Regulatory issues add uncertainty, and the management's vague future outlook further exacerbates investor concerns. The overall sentiment is strongly negative, with potential stock decline exceeding -8%.
Semler Scientific, Inc. (NASDAQ:SMLR) Q4 2024 Earnings Call Transcript
Unknown2-19
The company's earnings call presents mixed signals. While there are strong positives like record cash generation, significant Bitcoin holdings, and EPS exceeding expectations, there are also concerns. The absence of a shareholder return plan, potential regulatory risks, and market risks associated with Bitcoin introduce uncertainties. Moreover, management's lack of clarity on 2025 expectations and the reliance on Bitcoin performance pose potential downsides. The convertible note offering and market capitalization growth are positive, but the overall sentiment remains neutral due to the balance of risks and opportunities.
SMLR Slides
SMLR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
